PCTU DELEGATION ADVANCES ACADEMIC AND RESEARCH COLLABORATION AT THE OHIO STATE UNIVERSITY
,

As part of its strategic initiative to expand international partnerships in medical education, oncology research, and digital health innovation, Phan Chau Trinh University (PCTU) conducted a two-day official visit to The Ohio State University (OSU) on October 2–3, 2025. The working trip took place primarily at The James Cancer Hospital and The Solove Biomedical Research Institute, two of OSU’s most renowned centers for clinical and translational research. The visit aimed to explore opportunities for academic exchange, collaborative oncology research, and integration of artificial intelligence into clinical practice.

The delegation conducted a two-day official visit to The Ohio State University (OSU), mainly at The James Cancer Hospital and The Solove Biomedical Research Institute, with the purpose of exploring opportunities for collaboration in academic exchange, clinical oncology, biomedical research, and AI applications in medicine.

The visit began with an introduction meeting with representatives from the Office of Global Health, including Dr. Diane Gorgas, Dr. Mahr, Pamela Potter, and Kevin Douglas, who provided an overview of OSU’s international programs. The delegation then toured The James Cancer Hospital with Dr. Husain, Assistant Professor of Oncology, and met Dr. Matthew Kalady, Director of Colon and Rectal Surgery, to discuss potential physician exchanges, lectures, and collaboration opportunities.

The delegation toured the Clinical Skills Lab led by Amy Helder, Associate Director. The center is equipped with surgical theatres, simulation suites, and high-fidelity models used for training students, residents, and hospital staff. Amy welcomed future collaboration with the PCTU Simulation Center. The team also visited facilities within the James Hospital and Solove Institute, including the patient recovery dormitory, staff wellness pods, and simulation training areas.

A key part of the visit was the meeting with Dr. David Carbone, a leading thoracic oncology researcher.

The team again met with Dr. Kalady to explore translational research in colorectal cancer. He is leading an early-detection biomarker study and is seeking diverse international samples, including from Southeast Asia. Potential collaboration includes sample collection, data analysis, shared protocols, and training in molecular pathology and genomics.

Ảnh minh họa

Dr. Carbone is interested in joint research in AI-assisted diagnostics, multi-ancestry genomics, biomarker discovery, and clinical trial partnerships. He also provided a comprehensive lab tour, introduced his research team, invited the delegation to a research meeting.

The team again met with Dr. Kalady to explore translational research in colorectal cancer. He is leading an early-detection biomarker study and is seeking diverse international samples, including from Southeast Asia. Potential collaboration includes sample collection, data analysis, shared protocols, and training in molecular pathology and genomics.

Ảnh minh họa

At The James Emergency Department, discussions centered on operational challenges in oncology emergencies and OSU’s use of AI in dermatologic triage, pulmonary embolism prediction, sepsis alerts, and workflow optimization. Joint opportunities include AI-based triage and predictive modelling.

OSU also introduced the Global One Health Initiative, one of its largest interdisciplinary programs, involving collaborations across Africa, Asia, and Latin America. Key areas include zoonotic disease prevention, antimicrobial resistance, environmental health, food safety, and digital research systems. As OSU is reviewing its partnerships to focus on high-impact collaborations, PCTU may have an opportunity to become one of the prioritized partners.

The visit to The Ohio State University represents a significant advancement in PCTU’s international engagement strategy. While large-scale joint research may require further development, the discussions opened strong pathways for long-term collaboration in medical education, clinical oncology, translational research, and AI-driven healthcare innovation. The positive reception from OSU leadership and research teams establishes a strong foundation for a future partnership that aligns with PCTU’s vision of global academic excellence and research capacity building.